Thus, enriched bivalency at ADRA2A promoter depicted by both H3K4me3 and H3K27me3 enhancement in DLPFC of schizophrenia subjects would render ADRA2A gene poised for transcriptional action. This evidence concerns the gene ADRA2A and schizophrenia.